GBT to Announce Second Quarter 2020 Financial Results on Wednesday, August 5, 2020
July 29 2020 - 8:00AM
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced
that it will report second quarter 2020 financial results on
Wednesday, August 5, 2020, after U.S. financial markets close.
Management will host a conference call on Wednesday, August 5,
2020, at 4:30 p.m. ET to provide a general business update and to
discuss second quarter 2020 financial results. To participate in
the conference call, please dial 877-407-3982 (domestic) or
201-493-6780 (international). A live audio webcast of the
conference call can be accessed on GBT’s website at www.gbt.com
under the Investors section. An archived audio webcast will be
available for one month following the event.
About Global Blood TherapeuticsGlobal Blood
Therapeutics (GBT) is a biopharmaceutical company dedicated to the
discovery, development, and delivery of life-changing treatments
that provide hope to underserved patient communities. Founded in
2011, GBT is delivering on its goal to transform the treatment and
care of sickle cell disease (SCD), a lifelong, devastating
inherited blood disorder. The company has introduced Oxbryta®
(voxelotor), the first FDA-approved treatment that directly
inhibits sickle hemoglobin polymerization, the root cause of red
blood cell sickling in SCD. GBT is also advancing its pipeline
program in SCD with inclacumab, a p-selectin inhibitor in
development to address pain crises associated with the disease. In
addition, GBT’s drug discovery teams are working on new targets to
develop the next generation of treatments for SCD. To learn more,
please visit www.gbt.com and follow the company on Twitter
@GBT_news.
Contact
Information:
Steven Immergut (media)650-410-3258simmergut@gbt.com
Stephanie Yao (investors) 650-741-7730 syao@gbt.com
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Apr 2023 to Apr 2024